1. Home
  2. AAL vs BIO Comparison

AAL vs BIO Comparison

Compare AAL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Airlines Group Inc.

AAL

American Airlines Group Inc.

HOLD

Current Price

$11.14

Market Cap

8.6B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$278.65

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAL
BIO
Founded
1930
1952
Country
United States
United States
Employees
133700
7450
Industry
Air Freight/Delivery Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
7.1B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
AAL
BIO
Price
$11.14
$278.65
Analyst Decision
Buy
Strong Buy
Analyst Count
18
4
Target Price
$15.84
$358.50
AVG Volume (30 Days)
71.8M
276.2K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$54,633,000,000.00
N/A
Revenue This Year
$10.80
$2.74
Revenue Next Year
$5.27
$3.05
P/E Ratio
$63.15
$9.72
Revenue Growth
0.78
N/A
52 Week Low
$8.50
$211.43
52 Week High
$16.50
$343.12

Technical Indicators

Market Signals
Indicator
AAL
BIO
Relative Strength Index (RSI) 46.19 54.30
Support Level $10.99 $256.85
Resistance Level $11.34 $289.61
Average True Range (ATR) 0.41 7.89
MACD 0.13 2.09
Stochastic Oscillator 82.73 81.41

Price Performance

Historical Comparison
AAL
BIO

About AAL American Airlines Group Inc.

American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: